Aktie FREDUN6 FREDUN PHARMACEUTICALS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Fredun Pharmaceuticals Limited

Aktien

FREDUN6

INE194R01017

FREDUN6

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 09:00:43 18.05.2024 		% 5 Tage % 1. Jan.
880,4 INR 0,00 % Intraday Chart für Fredun Pharmaceuticals Limited +3,08 % +1,35 %
07.05. Fredun Pharmaceuticals Limited meldet Ergebnis für das am 31. März 2024 endende Geschäftsjahr CI
07.05. Fredun Pharmaceuticals Limited meldet Ergebnis für das vierte Quartal zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24
Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9%
Fredun Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Fredun Pharmaceuticals Secures Orders from Sea Countries, Expands Product Development in Veterinary Care, and Advances Orthopaedic Applications
Fredun Pharmaceuticals Limited Announces Appointment of Ms. Daisy Cyril Dsouza as Additional Independent Director
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Fredun Pharmaceuticals Limited Declared A Dividend At 7% on the Equity Shares of the Company for the Financial Year Ended March 31, 2023
Fredun Pharmaceuticals Limited Proposes Dividend for the Financial Year Ended March 31, 2023
Fredun Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Fredun Pharmaceuticals Limited Approves the Resignation of Dr. Chandrakant Shah as Independent Director
Fredun Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Fredun Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2022-23
Fredun Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Fredun Pharmaceuticals Limited announced that it has received INR 275.691377 million in funding
Fredun Pharmaceuticals Limited Announces Change in Registered Office Address
Fredun Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022
Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding
Fredun Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. FREDUN6 Aktie
  4. Nachrichten Fredun Pharmaceuticals Limited
  5. Andere Sprachen